Quick Takeaways
- Bleichroeder LP filed SCHEDULE 13G/A for Cue Biopharma, Inc. Common Stock, par value $0.001 per share (CUE).
- Disclosed ownership: 10%.
- Date of event: 19 Mar 2025.
Bleichroeder LP - 19 Mar 2025 SCHEDULE 13G/A Report for Cue Biopharma, Inc. Common Stock, par value $0.001 per share (CUE)
- Filing Manager
- Bleichroeder LP
- Reporting Manager
- Bleichroeder LP
- Symbol
- CUE
- Shares outstanding
- 61,337,958 shares
- Disclosed Ownership
- 6,127,662 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 21 Mar 2025, 19:14:43 UTC
- Date of event
- 19 Mar 2025
- Previous filing
- 07 Oct 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Bleichroeder LP disclosed 10% ownership in Cue Biopharma, Inc. Common Stock, par value $0.001 per share (CUE) on 19 Mar 2025."
What Changed
- Previous schedule filing date: 07 Oct 2024.
- Current filing was accepted on 21 Mar 2025, 19:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bleichroeder LP | 10% | 6,127,662 | 6,127,662 | 0 | Andrew Gundlach | Andrew Gundlach, Chairman and CEO | |
| Bleichroeder Holdings LLC | 10% | 6,127,662 | 6,127,662 | 0 | Andrew Gundlach | Andrew Gundlach, Chairman and CEO | |
| Andrew Gundlach | 10% | 6,127,662 | 6,127,662 | 0 | Andrew Gundlach | Andrew Gundlach, Individual |